Annual CFF
$3.65 M
+$3.65 M+1826100.00%
April 30, 2024
Summary
- As of February 8, 2025, ALZN annual cash flow from financing activities is $3.65 million, with the most recent change of +$3.65 million (+1826100.00%) on April 30, 2024.
- During the last 3 years, ALZN annual CFF has fallen by -$797.70 thousand (-17.93%).
- ALZN annual CFF is now -80.63% below its all-time high of $18.86 million, reached on April 30, 2022.
Performance
ALZN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$6.30 M
+$4.34 M+220.80%
October 31, 2024
Summary
- As of February 8, 2025, ALZN quarterly cash flow from financing activities is $6.30 million, with the most recent change of +$4.34 million (+220.80%) on October 31, 2024.
- Over the past year, ALZN quarterly CFF has increased by +$4.34 million (+220.80%).
- ALZN quarterly CFF is now -57.76% below its all-time high of $14.91 million, reached on July 31, 2021.
Performance
ALZN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$11.90 M
+$6.28 M+111.84%
October 31, 2024
Summary
- As of February 8, 2025, ALZN TTM cash flow from financing activities is $11.90 million, with the most recent change of +$6.28 million (+111.84%) on October 31, 2024.
- Over the past year, ALZN TTM CFF has increased by +$6.28 million (+111.84%).
- ALZN TTM CFF is now -38.31% below its all-time high of $19.28 million, reached on July 31, 2021.
Performance
ALZN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ALZN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | +220.8% | +111.8% |
| 3 y3 years | -17.9% | +220.8% | +111.8% |
| 5 y5 years | +1083.2% | +220.8% | +111.8% |
ALZN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -80.6% | >+9999.0% | at high | -100.0% | -36.9% | >+9999.0% |
| 5 y | 5-year | -80.6% | >+9999.0% | -57.8% | -100.0% | -38.3% | >+9999.0% |
| alltime | all time | -80.6% | >+9999.0% | -57.8% | -100.0% | -38.3% | >+9999.0% |
Alzamend Neuro Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | $6.30 M(+220.8%) | $11.90 M(+111.8%) |
| Jul 2024 | - | $1.96 M(+29.2%) | $5.62 M(+53.8%) |
| Apr 2024 | $3.65 M(>+9900.0%) | $1.52 M(-28.1%) | $3.65 M(+71.3%) |
| Jan 2024 | - | $2.11 M(>+9900.0%) | $2.13 M(>+9900.0%) |
| Oct 2023 | - | $18.10 K(>+9900.0%) | $18.30 K(+9050.0%) |
| Jul 2023 | - | $0.00(-100.0%) | $200.00(0.0%) |
| Apr 2023 | $200.00(-100.0%) | $200.00(>+9900.0%) | $200.00(-100.0%) |
| Jan 2023 | - | $0.00(0.0%) | $3.94 M(-0.0%) |
| Oct 2022 | - | $0.00(-100.0%) | $3.94 M(-79.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2022 | $18.86 M(+323.7%) | $3.94 M(>+9900.0%) | $18.86 M(+4.4%) |
| Jan 2022 | - | $400.00(-42.9%) | $18.06 M(-4.4%) |
| Oct 2021 | - | $700.00(-100.0%) | $18.90 M(-2.0%) |
| Jul 2021 | - | $14.91 M(+373.9%) | $19.28 M(+333.4%) |
| Apr 2021 | $4.45 M(+94.5%) | $3.15 M(+274.1%) | $4.45 M(+241.3%) |
| Jan 2021 | - | $841.00 K(+118.0%) | $1.30 M(+181.8%) |
| Oct 2020 | - | $385.70 K(+400.9%) | $462.70 K(+500.9%) |
| Jul 2020 | - | $77.00 K | $77.00 K |
| Apr 2020 | $2.29 M(+641.3%) | - | - |
| Apr 2019 | $308.70 K | - | - |
FAQ
- What is Alzamend Neuro annual cash flow from financing activities?
- What is the all time high annual CFF for Alzamend Neuro?
- What is Alzamend Neuro annual CFF year-on-year change?
- What is Alzamend Neuro quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Alzamend Neuro?
- What is Alzamend Neuro quarterly CFF year-on-year change?
- What is Alzamend Neuro TTM cash flow from financing activities?
- What is the all time high TTM CFF for Alzamend Neuro?
- What is Alzamend Neuro TTM CFF year-on-year change?
What is Alzamend Neuro annual cash flow from financing activities?
The current annual CFF of ALZN is $3.65 M
What is the all time high annual CFF for Alzamend Neuro?
Alzamend Neuro all-time high annual cash flow from financing activities is $18.86 M
What is Alzamend Neuro annual CFF year-on-year change?
Over the past year, ALZN annual cash flow from financing activities has changed by +$3.65 M (+1826100.00%)
What is Alzamend Neuro quarterly cash flow from financing activities?
The current quarterly CFF of ALZN is $6.30 M
What is the all time high quarterly CFF for Alzamend Neuro?
Alzamend Neuro all-time high quarterly cash flow from financing activities is $14.91 M
What is Alzamend Neuro quarterly CFF year-on-year change?
Over the past year, ALZN quarterly cash flow from financing activities has changed by +$4.34 M (+220.80%)
What is Alzamend Neuro TTM cash flow from financing activities?
The current TTM CFF of ALZN is $11.90 M
What is the all time high TTM CFF for Alzamend Neuro?
Alzamend Neuro all-time high TTM cash flow from financing activities is $19.28 M
What is Alzamend Neuro TTM CFF year-on-year change?
Over the past year, ALZN TTM cash flow from financing activities has changed by +$6.28 M (+111.84%)